1.Department of Clinical Pharmacology,Guangzhou Brain Hospital,Guangzhou 510370,China[2.Guangdong Key Laboratory of Chemical Emergency Test,National Analytical Center,Guangzhou 510070,China
{{custom_zuoZheDiZhi}}
{{custom_authorNodes}}
{{custom_bio.content}}
{{custom_bio.content}}
{{custom_authorNodes}}
Collapse
History+
Received
Published
2007-03-12
2008-05-10
Issue Date
2008-05-10
Abstract
OBJECTIVE To develop a rapid and sensitive HPLC-MS method for the analysis of rupatadine in human plasma,and study the pharmacokinetic characteristics of rupatadine fumarate tablets after a single oral dose of 10 mg in healthy volunteers.METHODS A single oral dose of 10 mg rupatadine fumarate tablets was given to 10 healthy volunteers.Blood samples were collected before dosing and at 0.25,0.5,0.75,1,1.5,2,3,4,6,8,10,12,16,24 h after a single oral dose of 10 mg.A HPLC-MS method was used to assay the concentration of rupatadine in plasma.The pharmacokinetic parameters were evaluated with PKS program.RESULTS The concentrations of rupatadine in plasma were discribed with a two-compartment model.The main pharmacokinetic parameters of rupatadine by oral administration were as follows:t1/2(5.3±1.7)h,tmax(0.8±0.1)h,ρmax(2.38±0.61)μg·L-1,AUC0-24(6.8±1.2)μg·h·L-1,AUC0-∞(7.3±1.3) μg ·h·L-1.CONCLUSION The analytical method appeared to be accurate,sensitive and convenient.The pharmacokinetic profile of rupatadine fumarate tablet was similar to the published reports.
WEN Yu-gun;YU Ling-hn;LIN Nn;M Cui;XIONG Ling-hui;HU Ho-ying;CHEN Jin-ling;ZHNG Ling;LIU Wen-xin.
Pharmacokinetics of Rupatadine Fumarate Tablets in Healthy Volunteers [J]. Chinese Pharmaceutical Journal, 2008, 43(10): 779-782
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] STUEBNER P,HORAK F,ZIEGLMAYER R,et al. Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber[J] .Ann Allergy Asthma Immunol,2006,96(1):37-44.
[2] BARBANOJ M J,GARCIA-GEA C,ANTONIJOAN R,et al. Evaluation of the cognitive,psychomotor and pharmacokinetic profiles of rupatadine,hydroxyzine and cetirizine,in combination with alcohol,in healthy volunteers[J] .Hum Psychopharmacol,2006 ,21(1):13-26.
[3] IZQUIERDO I,MERLOS M,GARCIA-RAFANELL J. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis[J] . Drugs Today (Barc),2003,39(6):451-468.